Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
3.380
-0.010 (-0.29%)
At close: Aug 28, 2026, 4:00 PM EDT
3.380
0.00 (-0.01%)
After-hours: Aug 28, 2026, 7:34 PM EDT
Cronos Group Revenue
Cronos Group had revenue of $53.01M in the quarter ending June 30, 2026, with 58.44% growth. This brings the company's revenue in the last twelve months to $179.09M, up 37.46% year-over-year. In the year 2025, Cronos Group had annual revenue of $146.59M with 24.63% growth.
Revenue (ttm)
$179.09M
Revenue Growth
+37.46%
P/S Ratio
6.93
Revenue / Employee
$293,585
Employees
610
Market Cap
1.24B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 146.59M | 28.97M | 24.63% |
| Dec 31, 2024 | 117.62M | 30.37M | 34.82% |
| Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
| Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
| Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
| Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
| Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
| Dec 31, 2018 | 12.12M | 8.97M | 285.16% |
| Dec 31, 2017 | 3.15M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | -572.29K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Perrigo Company | 4.14B |
| Phibro Animal Health | 1.52B |
| ANI Pharmaceuticals | 978.38M |
| Collegium Pharmaceutical | 808.21M |
| Pacira BioSciences | 746.16M |
| Amphastar Pharmaceuticals | 730.02M |
| Alvotech | 494.61M |
| Xeris Biopharma Holdings | 335.41M |
CRON News
- 3 days ago - The Best Way Marijuana Stock Investing Can Work For You - MarijuanaStocks
- 12 days ago - Surging Earnings Estimates Signal Upside for Cronos (CRON) Stock - Nasdaq
- 15 days ago - Marijuana reform is emerging as a midterm elections issue on both sides of the aisle - CNBC
- 17 days ago - Cronos (CRON) Q2 2026 Earnings Call Transcript - The Motley Fool
- 24 days ago - Cronos Group Q2 Earnings Call Highlights - MarketBeat
- 24 days ago - Is Cronos Group Inc (CRON) Undervalued After Q2 Earnings Beat with $53 Million Revenue? GF ... - GuruFocus
- 24 days ago - Cronos Group Earnings Call Transcript: Q2 2026 - Transcripts
- 24 days ago - Cronos Group Quarterly report: Q2 2026 - Filings